DTaP vaccine (Sanofi)

N/A

Report date: 2023/04/21 13:49:37

Base Information

Drug NameDTaP vaccine (Sanofi)
Drug Alias Name破伤风类毒素、减少的白喉毒素和无细胞百日咳疫苗（赛诺菲）COVAXiS破伤风类毒素、减少的白喉毒素和无细胞百日咳疫苗（Sanofi）Tdap-vaccineetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Sanofi) +[11] 
ClassificationVaccines > Vaccine type > Combination vaccineVaccines > Biological material > Toxoid vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsParturitionTetanusDiphtheria +[4] 
Global Approved IndicationsTetanusDiphtheriaWhooping Cough
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2005/06/10
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi PasteurShenzhen Sanofi Pasteur Biological Products Co Ltd
Inactive CompaniesAbo Holdings IncGcam Inc
Active IndicationsTetanusDiphtheriaWhooping Cough
Inactive IndicationsParturition

Other Information

ATC CodeJ07AF01J07AJ52J07AM51
Related LinksN/A